MAZAKALI Investment Platform
We help companies raise capital and investors place capital in cannabis. With confidence.
Sign up and get started!
Careful Curators of Opportunity
MAZAKALI is a turn-key platform for cannabis capital raising and investing. Investors in cannabis since 2014, the MAZAKALI leadership team brings over 150 years of finance, business strategy, legal, compliance and entrepreneurial experience to each client relationship.
Technology-enabled services include: capital advisory, investment banking, asset management and strategic consulting. Individual and institutional investor clients enjoy tailored portfolio management led by the industry’s first Outsourced Cannabis Investment Officer (OCIO) team. Client entrepreneurs and fund managers appreciate streamlined capital raising on the custom MAZAKALI investment portal.
Years of intimate conversations with industry pioneers fuel our knowledge and foster our relationships. Our connections create opportunity. Our conversations fuel innovation. We welcome purposeful investors to join us on this journey.
GreenPapers®. Cannabis is one of humankind’s most ancient healing herbs, with medical applications first recorded for over 100 ailments in 2737 BC by Emperor Shen Nung, the father of Chinese medicine. […] Jan 2020.
The State of Legal Cannabis Markets 2020 update is out. We are pleased to offer $100 off with code MAZAKALI100 when purchasing this authoritative source of data and insights into the legal cannabis industry. MAZAKALI Founder and CEO Sumit Mehta is the Finance and Strategy consultant to The Arcview Group, the largest private cannabis investor network in the United States.
MAZAKALI CEO Sumit Mehta moderated an interactive panel in Malta exploring medical cannabis from the perspectives of a global research scientist, a registered nutritionist and a cannabis banker. Topics included cannabis wellness-focused product innovation, medical safety and efficacy, and cannabis lifestyle integration. Video [19:08] Nov 2019.
Sumit Mehta presented in Malta on the increasing importance of cannabis as medicine in the world. China’s CBD impact on the global market was a highlight. Video [10:54] Nov 2019
Authority Through Knowledge
What is Hemp?
Hemp is cannabis and cannabis is hemp.
Differences are defined by history and use, by legality and by botany.
History & Use: Hemp has traditionally been used to describe plants grown for industrial use, plants that won’t get you ‘high’ but can be used to make clothing, rope and sails.
Legality: If a cannabis plant has THC content below 0.3%, it is considered hemp and therefore completely legal. This definition is socially constructed rather than being scientifically accurate.
Botany: Botanically speaking, there is more debate than there are conclusions on what is hemp vs. non-hemp cannabis.
So while there is plenty of debate around what is hemp and what is non-hemp cannabis, differences.are defined more by history and use than by genetics and botany.
With Privilege Comes Responsibility
As early entrants and investment leaders, we are driven by a passion and belief that purposeful cannabis investment will play a significant role Beyond Impact.
The MAZAKALI GreenPaper® has gained authority through knowledge on deep trends in the industry that matter to investors and operators alike.
MAZAKALI LLC (“MAZAKALI”) is an investment adviser registered with the state of California and is not a registered broker dealer. MAZAKALI’s principal, Sumit Mehta is an investment adviser representative of MAZAKALI and is also separately registered as an associated person of Growth Capital Services, Inc., a licensed broker-dealer and member of FINRA/SIPC (“GCS”), office of supervisory jurisdiction located at 582 Market Street, Suite 300, San Francisco, CA 94104. GCS and Mazakali are separate entities, and only certain securities brokered by Sumit Mehta are offered and sold through GCS. You can find more information about GCS and Mr. Mehta here and through FINRA Broker check.
Investment advisory services are provided exclusively from MAZAKALI’s San Francisco office. Registration as an investment adviser does not imply any particular skill or training. Any securities offered by Mr. Mehta are offered through GCS pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (“Securities Act”), and such private placements are not subject to the disclosure requirements that apply to registered securities under the Securities Act. Unregistered securities, and investments in the cannabis industry in particular, are speculative, and considered by regulators to involve a high degree of risk. Any descriptions of securities or companies on the MAZAKALI website do not constitute a recommendation, solicitation, or investment advice by MAZAKALI, GCS or its registered representatives, including Mr. Mehta.
Any statements other than those of historical fact are estimates only, and not an indication of any future investment performance. Past performance is not a guarantee of future results. Moreover, none of MAZAKALI, GCS, or any of its registered representatives makes any representation, warranty or guaranty of any kind, express or implied, as to the accuracy, completeness or reasonableness of the information contained on the MAZAKALI website, or of any other written or oral communication transmitted or made available to any interested party.
Offerings and services may only be available to certain investor types, classes and/or groups, depending upon the type of offering, various regulatory requirements, and/or the preferences of the issuer and their advisers; including, but not limited to, limiting deal access or investment capability to accredited investors. In the most sensible investment strategy, alternative investments should only be part of your overall investment portfolio. Potential investors are advised to consult with their tax, legal and financial advisors before making any investment.